Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial

Contemporary Clinical Trials Communications

Volumn 17, Issue , 2020, Pages

  Caponnetto, Pasquale ^a   Caruso, Massimo ^a   Maglia, Marilena ^a   Emma, Rosalia ^a   Saitta, Daniela ^a   Busà, Barbara ^b   Polosa, Riccardo ^a   Prosperini, Umberto ^c   Pennisi, Alfio ^d   Benfatto, Francesca ^a   Sartorio, Carlo ^a   Guastella, Matteo ^a   Mondati, Enrico ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UOC Farmacia Ospedaliera   (Italy)

^c Ospedale San Vincenzo   (Italy)

^d Casa di Cura Musumeci GECAS Srl   (Italy)

Author keywords

Acceptability; Effectiveness; Electronic cigarettes; Harm reduction; Heated tobacco products; IQOS; Just fog; Non inferiority trial; Smoking; Tolerability

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTINUING SMOKER; CONTROLLED STUDY; DEVICE COMPARISON; FEMALE; FOLLOW UP; HARM REDUCTION; HUMAN; MALE; NON-INFERIORITY TRIAL; NORMAL HUMAN; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING; SMOKING CESSATION; SMOKING REDUCTION; URINE SAMPLING;

EID: 85077914987     PISSN: 24518654     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conctc.2020.100518     Document Type: Article

References (28)

1. US Department of Health and Human Services, The Health Consequences of Smoking: 50 Years of Progress: a Report of the Surgeon General., 2014, US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
2. World Health Organization, WHO Report on the Global Tobacco Epidemic, 2008 – the MPOWER Package., 2008, World Health Organization, Geneva.
3. Doll, R., Peto, R., Boreham, J., Sutherland, I., Mortality in relation to smoking: 50 year observations on male British doctors. BMJ 328 (2004), 1519–1528.
4. Polosa, R., Benowitz, N.L., Treatment of nicotine addiction: present therapeutic options and pipeline developments. Trends Pharmacol. Sci. 32:5 (2011), 281–289.
5. Polosa, R., Rodu, B., Caponnetto, P., Maglia, M., Raciti, C., A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct. J., 10, 2013.
6. Adelman, D.J., Grainger, M., Ayala, V., Paxton, K., Tobacco: new years' resolutions + E-Cigs = Weaker volumes?. March 7, 2013, Morgan Stanley Research North America, New York.
7. Farsalinos, K.E., Romagna, G., Tsiapras, D., Kyrzopoulos, S., Voudris, V., Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int. J. Environ. Res. Public Health 11:4 (2014), 4356–4373.
8. EtterJF, Bullen, C., Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 106:11 (2011), 2017–2028.
9. FarsalinosKE, Polosa, R., Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarettes substitutes: a systematic review. Ther. Adv. Drug Saf. 5 (2014), 67–86.
10. Dockrell, M., Morrison, R., Bauld, L., McNeill, A., E-cigarettes: prevalence and attitudes in Great Britain. Nicotine Tob. Res. 15:10 (2013 Oct), 1737–1744.
11. Caponnetto, P., Campagna, D., Cibella, F., Morjiaria, J.B., Caruso, M., Russo, C., Polosa, R., EffiCiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8(6), 2013, e66317.
12. Dawkins, L., Corcoran, O., Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol. (Berl) 231:2 (2014), 401–407.
13. FarsalinosKE, Spyrou, A., Tsimopoulou, K., Stefopoulos, C., Romagna, G., Voudris, V., Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci. Rep., 4, 2014, 4133.
14. Frost-Pineda, K., Zedler, B.K., Oliveri, D., Liang, Q., Feng, S., Roethig, H.J., 12-Week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers. Regul. Toxicol. Pharmacol. 52 (2008), 111–117.
15. Roethig, H.J., Koval, T., Muhammad-Kah, R., Jin, Y., Mendes, P., Unverdorben, M., Short term effects of reduced exposure to cigarette smoke on white blood cells, platelets and red blood cells in adult cigarette smokers. Regul. Toxicol. Pharmacol. 57 (2010), 333–337.
16. Pisinger, C., ERS Tobacco Control Committee, ERS Position Paper on Tobacco Harm Reduction. 2019, European Respiratory Society https://www.ersnet.org/the-society/news/ers-position-paper-on-heated-tobacco-products. (Accessed 25 July 2019)
17. World Health Organization, WHO | Heated Tobacco Products (HTPs) Information Sheet. 2019, WHO http://www.who.int/tobacco/publications/prod_regulation/heated-tobacco-products/en/. (Accessed 25 July 2019)
18. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-Cigarettes. 2018, National Academies Press, Washington, D.C., 10.17226/24952.
19. Polosa, R., Caponnetto, P., Maglia, M., Morjaria, J.B., Russo, C., Success rates with nicotine personal vaporizers: a prospective a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health, 14, 2014, 1159.
20. Polosa, R., Caponnetto, P., Morjaria, J.B., Papale, G., Campagna, D., Russo, C., Effect of an electronic nicotine delivery device (E-cigarette) on smoking cessation and reduction: a prospective pilot study. BMC Public Health, 11, 2011, 786.
21. Tulloch, H.E., Pipe, A.L., Els, C., Clyde, M.J., Reid, R.D., Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. BMC Med., 14, 2016 Jun 7, 80.
22. Baker, T.B., Piper, M.E., Stein, J.H., Smith, S.S., Bolt, D.M., Fraser, D.L., et al. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: a randomized clinical trial. J. Am. Med. Assoc. 315:4 (2016), 371–379.
23. WHO, Report on the Global Tobacco Epidemic., 2013, World Health Organization, Geneva, Switzerland http://www.who.int/tobacco/global_report/2013/en.
24. http://www.epicentro.iss.it/passi/dati/fumo.asp. (Accessed 31 May 2018)
25. Gallus, S., Lugo, A., Pacifici, R., Pichini, S., Colombo, P., Garattini, S., La Vecchia, C., E-cigarette awareness, use, and harm perceptions in Italy: a national representative survey. Nicotine Tob. Res. 16:12 (2014 Dec), 1541–1548, 10.1093/ntr/ntu124.
26. http://www.epicentro.iss.it/temi/fumo/EpidItalia.asp. (Accessed 31 May 2018)
27. Liu, X., Lugo, A., Spizzichino, L., Tabuchi, T., Gorini, G., Gallus, S., Heat-not-burn tobacco products are getting hot in Italy. J. Epidemiol. 28:5 (2018 May 5), 274–275, 10.2188/jea.JE20180040.
28. Sedgwick, P., What is a non-inferiority trial?. BMJ, 347, 2013, f6853, 10.1136/bmj.f6853.